| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Extracorporeal Membrane Oxygenation | 11 | 2022 | 179 | 2.130 |
Why?
|
| Abnormalities, Multiple | 5 | 2013 | 234 | 1.210 |
Why?
|
| Heart Defects, Congenital | 8 | 2022 | 365 | 1.130 |
Why?
|
| Respiration, Artificial | 3 | 2015 | 350 | 0.780 |
Why?
|
| Infant | 25 | 2022 | 3118 | 0.740 |
Why?
|
| Parenchymal Tissue | 1 | 2020 | 6 | 0.710 |
Why?
|
| Infant, Newborn | 22 | 2022 | 2446 | 0.700 |
Why?
|
| Pleura | 1 | 2020 | 31 | 0.700 |
Why?
|
| Pulmonary Artery | 4 | 2013 | 317 | 0.690 |
Why?
|
| Hypoplastic Left Heart Syndrome | 4 | 2022 | 75 | 0.560 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2020 | 253 | 0.550 |
Why?
|
| Heart Septal Defects, Ventricular | 3 | 2022 | 69 | 0.550 |
Why?
|
| Child, Preschool | 16 | 2020 | 3678 | 0.540 |
Why?
|
| Aneurysm | 3 | 2007 | 60 | 0.540 |
Why?
|
| Cardiopulmonary Bypass | 4 | 2012 | 158 | 0.530 |
Why?
|
| Heart-Assist Devices | 4 | 2015 | 753 | 0.480 |
Why?
|
| Cineangiography | 1 | 2013 | 13 | 0.470 |
Why?
|
| Tracheobronchomalacia | 1 | 2013 | 11 | 0.460 |
Why?
|
| Vascular Malformations | 1 | 2013 | 19 | 0.460 |
Why?
|
| Retrospective Studies | 22 | 2022 | 8897 | 0.450 |
Why?
|
| Atrial Appendage | 1 | 2013 | 30 | 0.450 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2013 | 14 | 0.440 |
Why?
|
| Norwood Procedures | 2 | 2022 | 38 | 0.420 |
Why?
|
| Intra-Abdominal Hypertension | 1 | 2012 | 5 | 0.410 |
Why?
|
| Lactates | 2 | 2022 | 37 | 0.410 |
Why?
|
| Heart Block | 1 | 2012 | 31 | 0.410 |
Why?
|
| Heart Transplantation | 3 | 2015 | 720 | 0.400 |
Why?
|
| Hemodynamics | 6 | 2022 | 728 | 0.400 |
Why?
|
| Heart Septal Defects, Atrial | 2 | 2010 | 64 | 0.380 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2012 | 195 | 0.370 |
Why?
|
| Child | 15 | 2022 | 7090 | 0.350 |
Why?
|
| Expectorants | 1 | 2009 | 6 | 0.340 |
Why?
|
| Deoxyribonucleases | 1 | 2009 | 29 | 0.340 |
Why?
|
| Pulmonary Atelectasis | 1 | 2009 | 18 | 0.340 |
Why?
|
| Patient Transfer | 1 | 2010 | 96 | 0.330 |
Why?
|
| Registries | 1 | 2013 | 759 | 0.320 |
Why?
|
| Heart Failure | 2 | 2015 | 1172 | 0.320 |
Why?
|
| Aorta | 2 | 2007 | 286 | 0.320 |
Why?
|
| Treatment Outcome | 15 | 2022 | 8182 | 0.310 |
Why?
|
| Female | 29 | 2022 | 45769 | 0.290 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2013 | 2638 | 0.290 |
Why?
|
| Tetralogy of Fallot | 2 | 2012 | 44 | 0.280 |
Why?
|
| Humans | 42 | 2023 | 88633 | 0.270 |
Why?
|
| Critical Care | 1 | 2009 | 379 | 0.260 |
Why?
|
| Pulmonary Atresia | 2 | 2004 | 12 | 0.260 |
Why?
|
| Ductus Arteriosus | 2 | 2006 | 27 | 0.250 |
Why?
|
| Decision Making | 1 | 2010 | 661 | 0.240 |
Why?
|
| Male | 24 | 2022 | 42020 | 0.230 |
Why?
|
| Time Factors | 7 | 2015 | 5320 | 0.230 |
Why?
|
| Telangiectasia, Hereditary Hemorrhagic | 1 | 2023 | 15 | 0.220 |
Why?
|
| Central Nervous System Vascular Malformations | 1 | 2023 | 33 | 0.220 |
Why?
|
| Arteriovenous Malformations | 1 | 2023 | 45 | 0.210 |
Why?
|
| Sodium Bicarbonate | 1 | 2022 | 10 | 0.210 |
Why?
|
| Cardiac Surgical Procedures | 5 | 2013 | 473 | 0.210 |
Why?
|
| Follow-Up Studies | 6 | 2015 | 3657 | 0.200 |
Why?
|
| Cohort Studies | 5 | 2015 | 2837 | 0.190 |
Why?
|
| Gestational Age | 4 | 2013 | 322 | 0.190 |
Why?
|
| Propranolol | 2 | 2010 | 44 | 0.180 |
Why?
|
| Cough | 1 | 2020 | 55 | 0.170 |
Why?
|
| Hemangioma | 2 | 2010 | 64 | 0.170 |
Why?
|
| Dyspnea | 1 | 2020 | 75 | 0.170 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2010 | 104 | 0.170 |
Why?
|
| Fibrosis | 1 | 2020 | 237 | 0.160 |
Why?
|
| Rhabdomyoma | 1 | 1998 | 3 | 0.160 |
Why?
|
| Ultrasonography | 5 | 2013 | 705 | 0.160 |
Why?
|
| Adolescent | 7 | 2010 | 9161 | 0.160 |
Why?
|
| Cardiopulmonary Resuscitation | 2 | 2012 | 192 | 0.160 |
Why?
|
| Echocardiography | 5 | 2010 | 932 | 0.150 |
Why?
|
| Heart Neoplasms | 1 | 1998 | 63 | 0.150 |
Why?
|
| Heart Ventricles | 2 | 2022 | 779 | 0.140 |
Why?
|
| Hospital Mortality | 3 | 2022 | 381 | 0.140 |
Why?
|
| Injections, Intravenous | 2 | 2013 | 240 | 0.140 |
Why?
|
| Intensive Care Units, Pediatric | 2 | 2022 | 102 | 0.130 |
Why?
|
| Neuroblastoma | 1 | 2020 | 394 | 0.130 |
Why?
|
| Acute-Phase Proteins | 1 | 2015 | 37 | 0.120 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2015 | 50 | 0.120 |
Why?
|
| Antithrombin III | 1 | 2014 | 9 | 0.120 |
Why?
|
| Antithrombins | 1 | 2014 | 16 | 0.120 |
Why?
|
| Cardiac Catheterization | 2 | 2010 | 299 | 0.120 |
Why?
|
| Predictive Value of Tests | 3 | 2013 | 1709 | 0.110 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2013 | 54 | 0.110 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2015 | 266 | 0.110 |
Why?
|
| Hernia, Diaphragmatic | 1 | 2013 | 10 | 0.110 |
Why?
|
| Cyanosis | 1 | 2012 | 9 | 0.110 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2013 | 30 | 0.110 |
Why?
|
| Heparin | 1 | 2014 | 184 | 0.110 |
Why?
|
| Constriction, Pathologic | 1 | 2013 | 218 | 0.110 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2015 | 191 | 0.110 |
Why?
|
| Heart Septum | 1 | 2012 | 47 | 0.110 |
Why?
|
| Cause of Death | 1 | 2014 | 270 | 0.110 |
Why?
|
| Intubation, Intratracheal | 1 | 2013 | 146 | 0.100 |
Why?
|
| Ketamine | 1 | 2012 | 25 | 0.100 |
Why?
|
| Femoral Vein | 1 | 2012 | 39 | 0.100 |
Why?
|
| Risk Factors | 2 | 2015 | 5452 | 0.100 |
Why?
|
| Respiration | 1 | 2013 | 266 | 0.100 |
Why?
|
| Femoral Artery | 1 | 2012 | 83 | 0.100 |
Why?
|
| Critical Illness | 2 | 2012 | 305 | 0.100 |
Why?
|
| Jugular Veins | 1 | 2012 | 74 | 0.100 |
Why?
|
| Peritoneal Dialysis | 1 | 2012 | 31 | 0.100 |
Why?
|
| Hepacivirus | 1 | 2013 | 165 | 0.100 |
Why?
|
| Hepatitis C, Chronic | 1 | 2013 | 128 | 0.100 |
Why?
|
| Neuroprotective Agents | 1 | 2012 | 96 | 0.100 |
Why?
|
| Survival Analysis | 3 | 2012 | 1542 | 0.100 |
Why?
|
| Regression Analysis | 2 | 2010 | 594 | 0.100 |
Why?
|
| Career Choice | 1 | 2013 | 145 | 0.100 |
Why?
|
| Drug Administration Schedule | 2 | 2012 | 902 | 0.100 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2012 | 69 | 0.100 |
Why?
|
| Carotid Arteries | 1 | 2012 | 127 | 0.100 |
Why?
|
| Hospitals, Pediatric | 1 | 2012 | 109 | 0.090 |
Why?
|
| Survival Rate | 3 | 2009 | 1883 | 0.090 |
Why?
|
| Adrenal Insufficiency | 1 | 2010 | 23 | 0.090 |
Why?
|
| Postoperative Period | 2 | 2022 | 305 | 0.090 |
Why?
|
| Anticoagulants | 1 | 2014 | 423 | 0.090 |
Why?
|
| Hospitals, Special | 1 | 2010 | 7 | 0.090 |
Why?
|
| Tracheal Neoplasms | 1 | 2009 | 8 | 0.090 |
Why?
|
| Length of Stay | 3 | 2022 | 726 | 0.090 |
Why?
|
| Brain Injuries | 1 | 2012 | 163 | 0.090 |
Why?
|
| Lymphopenia | 1 | 2009 | 31 | 0.090 |
Why?
|
| Fetal Heart | 1 | 2009 | 13 | 0.080 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2012 | 342 | 0.080 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2009 | 32 | 0.080 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 2538 | 0.080 |
Why?
|
| Pulmonary Ventilation | 1 | 2009 | 33 | 0.080 |
Why?
|
| Biomarkers | 4 | 2022 | 1756 | 0.080 |
Why?
|
| Anesthesia, General | 1 | 2010 | 116 | 0.080 |
Why?
|
| Program Evaluation | 1 | 2010 | 303 | 0.080 |
Why?
|
| Contrast Media | 1 | 2013 | 1088 | 0.080 |
Why?
|
| Intraoperative Complications | 1 | 2010 | 188 | 0.080 |
Why?
|
| Risk Assessment | 2 | 2015 | 2286 | 0.080 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2007 | 9 | 0.080 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2007 | 242 | 0.080 |
Why?
|
| Dilatation, Pathologic | 1 | 2007 | 55 | 0.080 |
Why?
|
| Biliary Atresia | 1 | 2007 | 23 | 0.080 |
Why?
|
| Chromosome Aberrations | 1 | 2009 | 390 | 0.070 |
Why?
|
| Neutrophils | 1 | 2009 | 308 | 0.070 |
Why?
|
| Vena Cava, Superior | 1 | 2007 | 60 | 0.070 |
Why?
|
| Recombinant Proteins | 1 | 2009 | 1020 | 0.070 |
Why?
|
| Fontan Procedure | 2 | 2007 | 56 | 0.070 |
Why?
|
| Syndrome | 1 | 2007 | 448 | 0.070 |
Why?
|
| Foreign Bodies | 1 | 2007 | 65 | 0.070 |
Why?
|
| Incidence | 3 | 2013 | 1592 | 0.070 |
Why?
|
| Inflammation | 1 | 2012 | 961 | 0.070 |
Why?
|
| Methicillin Resistance | 1 | 2006 | 32 | 0.070 |
Why?
|
| Vena Cava, Inferior | 1 | 2007 | 144 | 0.070 |
Why?
|
| Heart Arrest | 1 | 2009 | 269 | 0.070 |
Why?
|
| Aneurysm, Ruptured | 1 | 2006 | 55 | 0.070 |
Why?
|
| Developmental Disabilities | 1 | 2007 | 202 | 0.070 |
Why?
|
| Bacteremia | 1 | 2006 | 102 | 0.060 |
Why?
|
| Prenatal Diagnosis | 2 | 2009 | 110 | 0.060 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2009 | 152 | 0.060 |
Why?
|
| Ebstein Anomaly | 1 | 2004 | 5 | 0.060 |
Why?
|
| Stroke | 1 | 2013 | 979 | 0.060 |
Why?
|
| Internship and Residency | 1 | 2013 | 1037 | 0.060 |
Why?
|
| Staphylococcal Infections | 1 | 2006 | 268 | 0.060 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 1843 | 0.060 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2003 | 96 | 0.050 |
Why?
|
| Vascular Resistance | 1 | 2022 | 102 | 0.050 |
Why?
|
| Head and Neck Neoplasms | 1 | 2010 | 1057 | 0.050 |
Why?
|
| Pericardium | 1 | 2003 | 70 | 0.050 |
Why?
|
| C-Reactive Protein | 2 | 2015 | 195 | 0.050 |
Why?
|
| Pacemaker, Artificial | 1 | 2003 | 93 | 0.050 |
Why?
|
| Bicarbonates | 1 | 2022 | 58 | 0.050 |
Why?
|
| Gases | 1 | 2022 | 30 | 0.050 |
Why?
|
| Autopsy | 2 | 2014 | 121 | 0.050 |
Why?
|
| Reoperation | 2 | 2003 | 604 | 0.050 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2003 | 177 | 0.050 |
Why?
|
| Aortic Valve | 1 | 2003 | 243 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2022 | 368 | 0.050 |
Why?
|
| Arkansas | 2 | 2010 | 3 | 0.050 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2003 | 224 | 0.050 |
Why?
|
| Young Adult | 2 | 2009 | 6220 | 0.050 |
Why?
|
| Coronary Angiography | 1 | 2000 | 238 | 0.040 |
Why?
|
| Prevalence | 1 | 2023 | 1252 | 0.040 |
Why?
|
| Pregnancy | 2 | 2009 | 2997 | 0.040 |
Why?
|
| Intensive Care Units | 2 | 2014 | 389 | 0.040 |
Why?
|
| Tachycardia, Supraventricular | 1 | 1998 | 16 | 0.040 |
Why?
|
| Heart Diseases | 1 | 2000 | 297 | 0.040 |
Why?
|
| Thrombosis | 1 | 2000 | 301 | 0.040 |
Why?
|
| Oxygen | 1 | 2022 | 743 | 0.040 |
Why?
|
| Lung | 1 | 2023 | 1243 | 0.030 |
Why?
|
| Aortopulmonary Septal Defect | 1 | 1996 | 1 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2000 | 1588 | 0.030 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 1996 | 40 | 0.030 |
Why?
|
| Age Factors | 1 | 2000 | 1863 | 0.030 |
Why?
|
| Fibrinogen | 1 | 2015 | 56 | 0.030 |
Why?
|
| Adrenergic alpha-1 Receptor Agonists | 1 | 1994 | 4 | 0.030 |
Why?
|
| Aorta, Thoracic | 1 | 1996 | 166 | 0.030 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 1994 | 33 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2012 | 3444 | 0.030 |
Why?
|
| Norepinephrine | 1 | 1994 | 170 | 0.030 |
Why?
|
| Adrenal Glands | 1 | 2014 | 77 | 0.030 |
Why?
|
| Hyperbilirubinemia | 1 | 1993 | 21 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2012 | 4271 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2013 | 293 | 0.030 |
Why?
|
| Hip | 1 | 2012 | 18 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 1994 | 433 | 0.030 |
Why?
|
| Intention to Treat Analysis | 1 | 2012 | 69 | 0.030 |
Why?
|
| Pulmonary Veins | 1 | 1993 | 92 | 0.030 |
Why?
|
| Rotation | 1 | 2012 | 91 | 0.030 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2012 | 35 | 0.030 |
Why?
|
| Hemorrhage | 1 | 2014 | 276 | 0.030 |
Why?
|
| Adult | 2 | 2009 | 26357 | 0.030 |
Why?
|
| Body Height | 1 | 2012 | 100 | 0.030 |
Why?
|
| Patient Positioning | 1 | 2012 | 64 | 0.020 |
Why?
|
| Central Nervous System | 1 | 2012 | 153 | 0.020 |
Why?
|
| Linear Models | 1 | 2012 | 423 | 0.020 |
Why?
|
| Adrenal Cortex Function Tests | 1 | 2010 | 2 | 0.020 |
Why?
|
| Body Weight | 1 | 2012 | 455 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2014 | 373 | 0.020 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2010 | 131 | 0.020 |
Why?
|
| Child Development | 1 | 2012 | 166 | 0.020 |
Why?
|
| Photography | 1 | 2010 | 37 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2010 | 1945 | 0.020 |
Why?
|
| Infant, Premature | 1 | 2012 | 294 | 0.020 |
Why?
|
| Vincristine | 1 | 2009 | 112 | 0.020 |
Why?
|
| Alanine Transaminase | 1 | 2009 | 74 | 0.020 |
Why?
|
| Laryngoscopy | 1 | 2009 | 45 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2012 | 867 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2009 | 92 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2009 | 289 | 0.020 |
Why?
|
| Genetic Counseling | 1 | 2009 | 101 | 0.020 |
Why?
|
| Hydrocortisone | 1 | 2010 | 303 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2009 | 360 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2010 | 683 | 0.020 |
Why?
|
| Cytokines | 1 | 2012 | 801 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2012 | 1716 | 0.020 |
Why?
|
| Bronchoscopy | 1 | 2009 | 157 | 0.020 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2009 | 277 | 0.020 |
Why?
|
| Pregnancy Outcome | 1 | 2009 | 253 | 0.020 |
Why?
|
| ROC Curve | 1 | 2009 | 773 | 0.020 |
Why?
|
| Community-Acquired Infections | 1 | 2006 | 64 | 0.020 |
Why?
|
| Disease Progression | 1 | 2009 | 1490 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 2746 | 0.010 |
Why?
|
| Infant Welfare | 1 | 2003 | 6 | 0.010 |
Why?
|
| Washington | 1 | 2003 | 49 | 0.010 |
Why?
|
| Tricuspid Atresia | 1 | 2003 | 4 | 0.010 |
Why?
|
| Pulmonary Valve | 1 | 2003 | 34 | 0.010 |
Why?
|
| Child Welfare | 1 | 2003 | 39 | 0.010 |
Why?
|
| Heart Septal Defects | 1 | 2003 | 32 | 0.010 |
Why?
|
| Polytetrafluoroethylene | 1 | 2003 | 74 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 2003 | 198 | 0.010 |
Why?
|
| Morbidity | 1 | 2003 | 149 | 0.010 |
Why?
|
| Electrodes, Implanted | 1 | 2003 | 177 | 0.010 |
Why?
|
| Heart Valve Diseases | 1 | 2003 | 115 | 0.010 |
Why?
|
| Thromboembolism | 1 | 2003 | 120 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 2003 | 341 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2010 | 2595 | 0.010 |
Why?
|
| Brain | 1 | 2012 | 2268 | 0.010 |
Why?
|
| Mitral Valve | 1 | 2003 | 260 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2003 | 1001 | 0.010 |
Why?
|
| Brimonidine Tartrate | 1 | 1994 | 1 | 0.010 |
Why?
|
| Yohimbine | 1 | 1994 | 7 | 0.010 |
Why?
|
| Prazosin | 1 | 1994 | 10 | 0.010 |
Why?
|
| Muscle Relaxation | 1 | 1994 | 18 | 0.010 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 1994 | 45 | 0.010 |
Why?
|
| Quinoxalines | 1 | 1994 | 50 | 0.010 |
Why?
|
| Arginine | 1 | 1994 | 138 | 0.010 |
Why?
|
| Exchange Transfusion, Whole Blood | 1 | 1993 | 18 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 1994 | 279 | 0.010 |
Why?
|
| Swine | 1 | 1994 | 582 | 0.010 |
Why?
|
| Portal Vein | 1 | 1993 | 119 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2003 | 2285 | 0.010 |
Why?
|
| Animals | 1 | 1994 | 27235 | 0.000 |
Why?
|